Low-level production of interleukin-13 in synovial fluid and tissue from patients with arthritis

Clinical Immunology and Immunopathology

Volumn 85, Issue 2, 1997, Pages 210-220

  Woods, James M ^a   Kenneth Haines, G ^b   Shah, Manisha R ^c   Rayan, Ghazi ^d   Koch, Alisa E ^a  

^a Department of Medicine ^*  (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c DEPARTMENT OF VETERANS AFFAIRS   (United States)

^d Hand and Microsurgery Center   (United States)

Author keywords

Interleukin 13; Rheumatoid arthritis; Synovium

Indexed keywords

CHEMOKINE; CYTOKINE; HEMOPOIETIC GROWTH FACTOR; INTERLEUKIN 13; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; PADGEM PROTEIN; PHYTOHEMAGGLUTININ; RANTES;

ARTHRITIS; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; MONONUCLEAR CELL; OSTEOARTHRITIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; SYNOVIUM; TISSUE CULTURE;

EID: 0030856227     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1997.4441     Document Type: Article

References (80)

1. Harris, E. D., Jr., Rheumatoid arthritis. Pathophysiology and implications for therapy. N. Engl. J. Med. 322,1277-1289,1990.
2. Koch, A. E., Kunkel, S. L., and Strieter, R. M., Cytokines in rheumatoid arthritis. J. Invest. Med. 43, 28-38, 1995.
3. Koch, A. E., and Strieter, R. M., "Chemokines and Disease," Chapman & Hall, New York, 1996.
4. de Vries, J. E., and Zurawski, G., Immunoregulatory properties of IL-13: Its potential role in atopic disease. Int. Arch. Allergy Immunol. 106, 175-179, 1995.
5. McKenzie, A. N., Culpepper, J. A., de Waal Malefyt, R., Briere, F., Punnonen, J., Aversa, G., Sato, A., Dang, W., Cocks, B. G., Menon, S., de Vries, J. E., Banchereau, J., Zurawski, G., Interleukin 13, a T-cell-derived cytokine that regulates human monocyte and B-cell function. Proc. Natl. Acad. Sei. USA 90, 3735-3739, 1993.
6. Minty, A., Chalon, J.-C., Guillemot, M., Kaghad, M., Labit, C., Leplatois, P., Liazun, P., Miloux, B., Minty, C., Casellas, P., Loison, G., Lupker, J., Shire, D., Ferrara, P., and Caput, D., Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 362, 248-250, 1993.
7. Gaston, H., Synovial lymphocytes and the aetiology of synovitis. Ann. Rheum. Dis.52(Suppl. 1), S17-S21, 1993.
8. Mima, T., Saeki, Y., Ohshima, S., Nishimoto, N., Matsushita, M., Shimizu, M., Kobayashi, Y., Nomura, T., and Kishimoto, T., Transfer of rheumatoid arthritis into severe combined immunodeficient mice. The pathogenetic implications of T cell populations oligoclonally expanding in the rheumatoid joints. J. Clin. Invest. 96, 1746-1758, 1995.
9. Mosmann, T. R., and Coffman, R. L., TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7, 145-173, 1989.
10. Smirnov, D. V., Smirnova, M. G., Korobko, V. G., and Frolova, E. I., Tandem arrangement of human genes for interleukin-4 and interleukin-13: Resemblance in their organization. Gene 155, 277-281, 1995.
11. Zurawski, S. M., Vega, F., Jr., Huyghe, B., and Zurawski, G., Receptors for interleukin-13 and interleukin-4 are complex and share a novel component that functions in signal transduction. EMBO J. 12, 2663-2670, 1993.
12. Lin, J. X., Migone, T. S., Tsang, M., Friedmann, M., Weatherbee, J. A., Zhou, L., Yamauchi, A., Bloom, E. T., Mietz, J., John, S., Leonard, W. J., The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15. Immunity 2, 331-339, 1995.
13. Vita, N., Lefort, S., Laurent, P., Caput, D., and Ferrara, P., Characterization and comparison of the interleukin 13 receptor with the interleukin 4 receptor on several cell types. J. Biol. Chem. 270, 3512-3517, 1995.
14. de Waal Malefyt, R., Figdor, C. G., Huijbens, R., Mohan-Peterson, S., Bennett, B., Culpepper, J., Dang, W., Zurawski, G., and de Vries, J. E., Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. J. Immunol. 11, 6370-6381, 1993.
15. + Th0, Th1 and Th2 T cell clones and EBV-transformed B cells. Int. Immunol. 7, 1405-1416, 1995.
16. + T cells: Modulation by interleukin-4 and interleukin-12. Eur. J. Immunol. 26, 571-577, 1996.
17. Burd, P. R., Thompson, W. C., Max, E. E., and Mills, F. C., Activated mast cells produce interleukin 13. J. Exp. Med. 181,1373-1380, 1995.
18. Marietta, E. V., Chen, Y., and Weis, J. H., Modulation of expression of the anti-inflammatory cytokines interleukin-13 and interleukin-10 by interleukin-3. Eur. J. Immunol. 26,49-56,1996.
19. Li, H., Sim, T. C., and Alam, R., IL-13 released by and localized in human basophils. J. Immunol. 156, 4833-4838, 1996.
20. Cosentino, G., Soprana, E., Thienes, C. P., Siccardi, A. G., Viale, G., and Vercelli, D., IL-13 down-regulates CD14 expression and TNF-alpha secretion in normal human monocytes. J. Immunol. 155, 3145-3151, 1995.
21. Viale, G., and Vercelli, D., Interleukin-13 regulates the phenotype and function of human monocytes. Int. Arch. Allergy Immunol. 107, 176-178, 1995,
22. Hart, P. H., Ahern, M. J., Smith, M. D., and Finlay-Jones, J. J., Regulatory effects of IL-13 on synovial fluid macrophages and blood monocytes from patients with inflammatory arthritis. Clin. Exp. Immunol. 99, 331-337, 1995.
23. Kim, C., Schinkel, C., Fuchs, D., Stadier, J., Walz, A., Zedler, S., von Donnersmarck, G. H., and Faist, E., Interleukin-13 effectively down-regulates the monocyte inflammatory potential during traumatic stress. Arch. Surg. 130, 1330-1336, 1995.
24. Vannier, E., de Waal Malefyt, R., Salazar-Montes, A., de Vries, J. E., and Dinarello, C. A., Interleukin-13 (IL-13) induces IL-1 receptor antagonist gene expression and protein synthesis in peripheral blood mononuclear cells: Inhibition by an IL-4 mutant protein. Blood 87, 3307-3315, 1996.
25. Muzio, M., Re, F., Sironi, M., Polentarutti, N., Minty, A., Caput, D., Ferrara, P., Mantovani, A., and Colotta, F., Interleukin-13 induces the production of interleukin-1 receptor antagonist (IL-1ra) and the expression of the mRNA for the intracellular (keratinocyte) form of IL-lra in human myelomonocytic cells. Blood 83, 1738-1743, 1994.
26. Bochner, B. S., Hunk, D. A., Sterbinsky, S. A., Coffman, R. L., and Schleimer, R. P., IL-13 selectively induces vascular cell adhesion molecule-1 expression in human endothelial cells. J. Immunol. 154, 799-803, 1995.
27. Zurawski, G., and de Vries, J., Interleukin 13, an interleukin-4 like cytokine that acts on monocytes and B cells, but not on T cells. Immunol. Today 15, 19-26, 1994.
28. Cash, E., Minty, A., Ferrara, P., Caput, D., Fradelizi, D., and Rott, O., Macrophage-inactivating IL-13 suppresses experimental autoimmune encephalomyelitis in rats. J. Immunol. 153, 4258-4267, 1994.
29. Marfaing-Koka, A., Devergne, O., Gorgone, G., Portier, A., Schall, T. J., Galanaud, P., and Emilie, D., Regulation of the production of the RANTES chemokine by endothelial cells: Synergistic induction by IFN-gamma plus TNF-α and inhibition by IL-4 and IL-13. J. Immunol. 154, 1870-1878, 1995.
30. Xi, X., Schlegel, N., Caen, J. P., Minty, A., Fournier, S., Caput, D., Ferrara, P., and Han, Z. C., Differential effects of recombinant human interleukin-13 on the in vitro growth of human haemopoietic progenitor cells. Br. J. Haematol. 90, 921-927, 1995.
31. Jacobsen, S. E., Okkenhaug, C., Veiby, O. P., Caput, D., Ferrara, P., and Minty, A;, Interleukin 13: Novel role in direct regulation of proliferation and differentiation of primitive hematopoietic progenitor cells. J. Exp. Med. 180, 75-82, 1994.
32. Sakamoto, O., Hashiyama, M., Minty, A., Ando, M., and Suda, T., Interleukin-13 selectively suppresses the growth of human macrophage progenitors at the late stage. Blood 85, 3487-3493, 1995.
33. Sironi, M., Sciacca, F. L., Matteucci, C., Conni, M., Vecchi, A., Bernasconi, S., Minty, A., Caput, D., Ferrara, P., Colotta, F., Mantovani, A., Regulation of endothelial and mesothelial cell function by interleukin-13: selective induction of vascular cell adhesion molecule-1 and amplification of interleukin-6 production. Blood 84, 1913-1921, 1994.
34. Bonnefoy, J. Y., Gauchat, J. F., Life, P., Graber, P., Aubry, J. P., and Lecoanet-Henchoz, S., Regulation of IgE synthesis by CD23/ CD21 interaction. Int. Arch. Allergy Immunol. 107,40-42,1995.
35. Punnonen, J., and de Vries, J. E., IL-13 induces proliferation, Ig isotype switching, and Ig synthesis by immature human fetal B cells. J. Immunol. 152, 1094-1102, 1994.
36. Defrance, T., Carayon, P., Billian, G., Guillemot, J. C., Minty, A., Caput, D., and Ferrara, P., Interleukin 13 is a B cell stimulating factor. J. Exp. Med. 179, 135-143, 1994.
37. Cocks, B. G., de Waal Malefyt, R., Galizzi, J. P., de Vries, J. E., and Aversa, G., IL-13 induces proliferation and differentiation of human B cells activated by the CD40 ligand. Int. Immunol. 5, 657-663, 1993.
38. Punnonen, J., Aversa, G., Cocks, B. G., McKenzie, A. N., Menon, S., Zurawski, G., de Waal Malefyt, R., and de Vries, J. E., Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc. Natl. Acad. Sci. USA 90, 3730-3734, 1993.
39. Arnett, F. C., Edworthy, S.M., Bloch, D.A., McShane, D.J., Fries, J. F., Cooper, N. S., Healey, L. A., Kaplan, S. R., Liang, M. H., Luthra, H. S., Medsger, T. A. J., Mitchell, D. M., Neustadt, D. H., Finals, R. S., Schaller, J. G., Sharp, J. T., Wilder, R. L., and Hunder, G. G., The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31, 315-324, 1988.
40. Altman, R., Asch, E., Bloch, D., Bole, G., Borenstein, D., Brandt, K., Christy, W., Cooke, T. D., Greenwald, R., Hochberg, M., Howell, D., Kaplan, D., Koopman, W., Longley, S., 3rd, Mankin, H., McShane, D. J., Medsger, T. J., Meenan, R., Mikkelsen, W., Moskowitz, R., Murphy, W., Rothschild, B., Segal, M., Sokoloff, L., and Wolfe, F., Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Arthritis Rheum. 29, 1039-1049, 1986.
41. Altman, R., Alarcon, G., Appelrouth, D., Bloch, D., Borenstein, D., Brandt, K, Brown, C., Cooke, T. D., Daniel, W., Feldman, D., Greenwald, R., Hochberg, M., Howell, D., Ike, R., Kapila, P., Kaplan, D., Koopman, W., Marino, C., McDonald, E., McShane, D. J., Medsger, T. J., Michel, B., Murphy, W. A., Osial, T., Ramsey-Goldman, R., Rothschild, B., and Wolfe, F., The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum. 34, 505-514, 1991.
42. Koch, A. E., Polverini, P. J., and Leibovich, S. J., Stimulation of neovascularization by human rheumatoid synovial tissue macrophages. Arthritis Rheum. 29, 471-479, 1986.
43. Koch, A. E., Polverini, P. J., and Leibovich, S. J., Functional heterogeneity of human rheumatoid synovial tissue macrophages. J. Rheumatol. 15, 1058-1063, 1988.
44. Koch, A. E., Kunkel, S. L., Burrows, J. G., Evanoff, H. L., Haines, G. K., Pope, R. M., and Stricter, R. M., Synovial tissue macrophage as a source of thé chemotactic cytokine IL-8. J. Immunol. 147, 2187-2195, 1991.
45. Koch, A. E., Kunkel, S. L., Shah, M. R., Hosaka, S., Halloran, M. M., Haines, G. K., Burdick, M. D., Pope, R. M., and Stricter, R. M., Growth-related gene product alpha. A chemotactic cytokine for neutrophils in rheumatoid arthritis. J. Immunol. 155, 3660-3666, 1995.
46. Desai-Mehta, A., Lu, L., Ramsey-Goldman, R., and Datta, S. K., Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. J. Clin. Invest. 97, 2063-2073, 1996.
47. Koch, A. E., Shah, M. R., Harlow, L. A., Lovis, R. M., and Pope, R. M., Soluble intercellular adhesion molecule-1 in arthritis. Clin. Immunol. Immunopathol. 71, 208-215, 1994.
48. Koch, A. E., Kunkel, S. L., Harlow, L. A., Johnson, B., Evanoff, H. L., Haines, G. K, Burdick, M. D., Pope, R. M., and Stricter, R. M., Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis. J. Clin. Invest. 90,772-779, 1992.
49. Evanoff, H. L., Burdick, M. D., Moore, S. A., Kunkel, S. L., and Stricter, R. M., A sensitive ELISA for the detection of human monocyte chemoattractant proteiri-1 (MCP-1). Immunol. Invest. 21, 39-45, 1992.
50. Hosaka, S., Shah, M. R., Pope, R. M.; and Koch, A. E., Soluble forms of P-selectin and intercellular adhesion molecule-3 in synovial fluids. Clin. Immunol. Immunopathol. 78,276-282,1996.
51. van der Pouw Kraan, T. C., Boeije, L. C., Troon, J.T., Rutschmann, S. K., Wijdenes, J., and Aarden, L. A., Human IL-13 production is negatively influenced by CD3 engagement. Enhancement of IL-13 production by cyclosporin A. J. Immunol. 156, 1818-1823, 1996.
52. Pawankar, R. U., Okuda, M., Hasegawa, S., Suzuki, K., Yssel, H., Okubo, K., Okumura, K., and Ra, C., Interleukin-13 expression in the nasal mucosa of perennial allergic rhinitis. Am. J. Respir. Crit. Care Med. 152, 2059-2067, 1995.
53. Cluitmans, F. H., Esendam, B. H., Landegent, J. E., Willemze, R., and Falkenburg, J. H., Constitutive in vivo cytokine and hematopoietic growth factor gene expression in the bone marrow and peripheral blood of healthy individuals. Blood 85, 20382044, 1995.
54. Kotake, S., Schumacher, H. R. J., Yarboro, C. H., Arayssi, T. K., Pando, J. A., Kanik, K S., Gourley, M. F., Klippel, J. H., and Wilder, R. L., In vivo gene expression of type 1 and type 2 cytokines in synovial tissues from patients in early stages of rheumatoid, reactive and undifferentiated arthritis. Arthritis Rheum. 39, S117, 1996.
55. Miossec, P., Naviliat, M., Dupuy d'Angeac, A., Sany, J., and Banchereau, J., Low levels of interleukin-4 and high levels of transforming growth factor beta in rheumatoid synovitis. Arthritis Rheum. 33, 1180-1187, 1990.
56. Dolhain, R.J., Van Der Heiden, A.N., Ter Haar, N.T., Breedveld, F. C., and Miltenburg, A. M., Shift toward T lymphocytes with a T helper 1 cytokine-secretion profile in the joints of patients with rheumatoid arthritis. Arthritis Rheum. 39, 1961-1969, 1996.
57. Bucht, A., Larsson, P., Weisbrot, L., Thorne, C., Pisa, P., Smedegard, G., Keystone, E. C., and Gronberg, A., Expression of interferon-gamma (IFN-gamma), IL-10, IL-12 and transforming growth factor-beta (TGF-beta) mRNA in synovial fluid cells from patients in the early and late phases of rheumatoid arthritis (RA). Clin. Exp. Immunol. 103, 357-367, 1996.
58. Gush, J. J., Splawski, J. B., Thomas, R., McFarlin, J. E., Schulze-Koops, H., Davis, L. S., Fujita, K., and Lipsky, P. E., Elevated interleukin-10 levels in patients with rheumatoid arthritis. Arthritis Rheum. 38, 96-104, 1995.
59. Isomaki, P., Luukkainen, R., Saario, R., Toivanen, P., and Punnonen, J., Interleukin-10 functions as an antiinflammatory cytokine in rheumatoid synovium. Arthritis Rheum. 39, 386-395, 1996.
60. Schlaak, J. F., Pfers, L, Meyer Zum Buschenfelde, K. H., and Marker-Hermann, E., Different cytokine profiles in the synovial fluid of patients with osteoarthritis, rheumatoid arthritis and seronegative spondylarthropathies. Clin. Exp. Rheumatol. 14, 155-162, 1996.
61. Lapadula, G., Iannone, F., Dell'Accio, F., Covelli, M., and Pipitone, V., Interleukin-10 in rheumatoid arthritis. Clin. Exp. Rheumatol. 13, 629-632, 1995.
62. Katsikis, P. D., Chu, C. Q., Brennan, F. M., Maini, R. N., and Feldmann, M., Immunoregulatory role of interleukin 10 in rheumatoid arthritis. J. Exp. Med. 179, 1517-1527, 1994.
63. Campbell, I. L., Kay, T. W., Oxbrow, L., and Harrison, L. C., Essential role for interferon-gamma and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice. J. Clin. Invest. 87, 739-742, 1991.
64. Kurosaka, M., and Ziff, M., Immunoelectron microscopic study of the distribution of T cell subsets in rheumatoid synovium. J. Exp. Med. 158, 1191-1210, 1983.
65. + T cells in synovial fluid and tissues of patients with rheumatoid arthritis. Arthritis Rheum. 24, 1370-1376, 1981.
66. Burmester, G. R., Jahn, B., Gramatzki, M., Zacher, J., and Kalden, J. R., Activated T cells in vivo and in vitro: Divergence in expression of Tac and la antigens in the nonblastoid small T cells of inflammation and normal T cells activated in vitro. J. Immunol. 133, 1230-1234, 1984.
67. Hogg, N., Palmer, D. G., and Revell, P. A., Mononuclear phagocytes of normal and rheumatoid synovial membrane identified by monoclonal antibodies. Immunology 56, 673-681, 1985.
68. Ulfgren, A. K., Lindblad, S., Klareskog, L., Andersson, J., and Andersson, U., Detection of cytokine producing cells in the synovial membrane from patients with rheumatoid arthritis. Ann. Rheum. Dis. 54, 654-661, 1995.
69. Firestein, G. S., and Zvaifler, N. J., Peripheral blood and synovial fluid monocyte activation in inflammatory arthritis. II. Low levels of synovial fluid and synovial tissue interferon suggest that gamma-interferon is not the primary macrophage activating factor. Arthritis Rheum. 30, 864-871, 1987.
70. Husby, G., and Williams, R. C., Jr., Immunohistochemical studies of interleukin-2 and gamma-interferon in rheumatoid arthritis. Arthritis Rheum. 28, 174-181, 1985.
71. Firestein, G. S., Xu, W. D., Townsend, K, Broide, D., AlvaroGracia, J., Glasebrook, A., and Zvaifler, N. J., Cytokines in chronic inflammatory arthritis. I. Failure to detect T cell lymphokines (interleukin 2 and interleukin 3) and presence of macrophage colony-stimulating factor (CSF-1) and a novel mast cell growth factor in rheumatoid synovitis. J. Exp. Med. 168, 1573-1586, 1988.
72. Egeland, T., and Lund, H., Immunoregulatory lymphokines in rheumatoid joints. I. Search for interleukin 2 in synovial fluid. Scand. J. Immunol. 25, 101-106, 1987.
73. Isomaki, P., Luukkainen, R., Toivanen, P., and Punnonen, J., The presence of interleukin-13 in rheumatoid synovium and its antiinflammatory effects on synovial fluid macrophages from patients with rheumatoid arthritis. Arthritis Rheum. 39, 1693-1702, 1996.
74. Westacott, C.I., Whicher, J.T., Barnes, I.C., Thompson, D., Swan, A. J., and Dieppe, P. A., Synovial fluid concentration of five different cytokines in rheumatic diseases. Ann. Rheum. Dis. 49, 676-681, 1990.
75. Neidel, J., Schulze, M., and Lindschau, J., Association between degree of bone-erosion and synovial fluid-levels of tumor necrosis factor alpha in the knee-joints of patients with rheumatoid arthritis. Inflammation Res. 44, 217-221, 1995.
76. Warnatz, H., Ruschen, S., and Lemm, G., Interleukin-1 in the pathogenesis of chronic polyarthritis. Med. Klin. 85, 302-307, 1990.
77. Fong, K. Y., Boey, M. L., Koh, W. H., and Feng, P. H., Cytokine concentrations in thé synovial fluid and plasma of rheumatoid arthritis patients: Correlation with bony erosions. Clin. Exp. Rheumatol. 12, 55-58, 1994.
78. Miossec, P., Kashiwado, T., and Ziff, M., Inhibitor of interleukin-2 in rheumatoid synovial fluid. Arthritis Rheum. 30, 121-129, 1987.
79. Arend, W. P., and Dayer, J. M., Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis. Arthritis Rheum. 38, 151-160, 1995.
80. Bessis, N., Boissier, M. G., Ferrara, P., Blankenstein, T., Fradelizi, D., and Fournier, C., Attenuation of collagen-induced arthritis in mice by treatment with vector cells engineered to secrete interleukin-13. Eur. J. Immunol. 26, 2399-2403, 1996.